Orthofix Investor Presentation Deck

2023 Full Year Guidance es $739 – 744M Revenue $42 - 46M Adjusted EBITDA Revenue ranges above represent 5.4% to 6.2% proforma growth rates over prior year Guidance information is as of November 8, 2023, based on guidance provided by Orthofix leadership on that date. Inclusion of this information in this presentation is not a confirmation or an update of, and should not be construed or otherwise assumed to reflect ay confirmation or update of, that guidance by Orthofix leadership as of any date other than November 8, 2023. Ⓒ2023 Orthofix Medical Inc. All rights reserved | 15 ORTHOFIX® SeaSpine.

View entire presentation